Data as of Apr 17
| +0.76 / +3.07%|
The 2 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 38.00, with a high estimate of 40.00 and a low estimate of 36.00. The median estimate represents a +48.73% increase from the last price of 25.55.
The current consensus among 2 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.